在心力衰竭患者中,虚弱和功能之间的相互作用.
Ángela Rodríguez-Eguren1, José Jesús Broseta2,3,4,5, Lydia Izquierdo1
1Heart Failure and Heart Transplant Unit, Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, 08007 Barcelona, Spain.
Life (Basel, Switzerland)
|January 28, 2026
概括
心力衰竭患者的脆弱性很常见,并且随着功能下降而恶化. 结合脆弱性和病评估,可以识别高风险个体,以更好地管理心力衰竭.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 老年病的医生 老年病的医生
背景情况:
- 在心力衰竭 (HF) 患者中,脆弱性很普遍,预测结果不佳.
- 慢性病 (CKD) 通常与HF共存,可能加剧脆弱性和风险.
- 在HF门诊患者中,脆弱性和CKD之间的相互作用需要进一步的表征.
研究的目的:
- 确定与HF门诊患者的虚弱相关的患病率和临床因素.
- 评估慢性脏病不同阶段的虚弱预后的影响.
- 研究虚弱和CKD对心血管不良事件的综合影响.
主要方法:
- 一项459名高风门诊患者的前性观察队列研究.
- 使用弗里德的表型 (≥3标准) 评估的脆弱性.
- 虚弱相关的后勤回归;结果 (死亡率/HF住院) 和CKD相互作用的考克斯模型.
主要成果:
- 骨折的发病率为39.9%,随着CKD的严重程度的增加 (14%至48%).
- 脆弱的独立预测因素包括年龄较大,中风史,较高的CA125和较低的eGFR.
- 虚弱的患者面临死亡/HF住院的风险增加了一倍 (aHR 2.09),晚期CKD的风险增加了5倍.
结论:
- 虚弱性在HF门诊患者中很常见,并与功能障碍密切相关.
- 先进的CKD显著放大了HF脆弱的不良预后.
- 对脆弱性和功能进行综合评估对于风险分层和个性化HF治疗至关重要.
更多相关视频
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
17.0K
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
1.1K
相关概念视频
01:11Renal Failure: Dose Adjustments
463
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
463
01:29Heart Failure II: Pathophysiology
872
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
872
01:17Pathophysiology of Heart Failure
3.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
01:27Heart Failure I: Introduction
847
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
847
01:22Heart Failure VI: Adjunct Therapies
314
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
314
01:22Heart Failure Drugs: Diuretics
948
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
948